C-ABL-IN-3
Product Specifications
CAS Number
2626934-64-1
Target
Others|||Bcr-Abl
Related Pathways
Angiogenesis|||Others|||Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors
Bioactivity
C-ABL-IN-3, a highly effective c-Abl inhibitor, exhibits promising potential for studying neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), as well as cancer [1]. The activation of c-Abl has been strongly implicated in a range of diseases, notably cancer [1]. It offers valuable opportunities for research in these fields [1].
Smiles
O=C1N(C=C(C(NC2=CC=C(OC(F)(F)F)C=C2)=O)C=C1)C=3C=NC=NC3
Molecular Formula
C17H11F3N4O3
Molecular Weight
376.29
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15116482 1 Vial
Lentiviral human UNC13B shRNA (UAS) - Lentiviral human UNC13B shRNA (UAS, GFP) plasmid
Ask
View Details ![Mouse Monoclonal MAP2 Antibody (2C4) [Alexa Fluor 647]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
